Preliminary Effect of a Health Information Literacy Enhancement Program for Individuals With Meta… (NCT07051733) | Clinical Trial Compass
By InvitationNot Applicable
Preliminary Effect of a Health Information Literacy Enhancement Program for Individuals With Metabolic Syndrome
China30 participantsStarted 2025-05-08
Plain-language summary
The purpose of this study is to evaluate the preliminary effect of a health-information literacy promotion program for individuals with Metabolic Syndrome (including its subtypes) based on the Health Empowerment Theory. The study aims to answer the following questions:
Does the intervention improve health information literacy among study participants? Does the intervention lead to better health outcomes, including weight, waist circumference, BMI control, and metabolic health indicators (blood pressure, blood glucose, glycated hemoglobin, and blood lipids)?
Participants will:
Undergo the intervention program for 6 weeks (face to face and online) and will be assessed regularly to monitor changes in their health information literacy and health outcomes.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 18 years old
* Patients diagnosed with metabolic syndrome (meeting ≥3 criteria):
* Waist circumference ≥ 90 cm (men) / ≥ 85 cm (women)
* Fasting glucose ≥ 6.1 mmol/L or OGTT 2h-glucose ≥ 7.8 mmol/L and/or diabetes treatment
* Blood pressure ≥ 130/85 mmHg and/or hypertension treatment
* Fasting triglycerides (TG) ≥ 1.70 mmol/L
* Fasting HDL-C \< 1.04 mmol/L
* Individuals with ≥1 metabolic abnormality not meeting full metabolic syndrome criteria
* Cognitively aware with literacy skills and voluntary participation
Exclusion Criteria:
* Severe hepatic/renal dysfunction, cancer, or life-threatening diseases
* Mental disorders, visual/hearing impairments, or intellectual disabilities
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Health Information Literacy
Timeframe: Measurements will be taken once before the formal intervention and once after the intervention ends (at 6 weeks).